LSSA is a fat-liquefaction device that uses ultrasound energy to melt fat. It was developed in Korea and received approval from the Ministry of Food and Drug Safety in 2021. Unlike non-invasive devices that deliver energy from above the skin, LSSA uses a thin probe (about 0.9 mm in diameter for facial use, similar to a typical injection needle) inserted through a needle-sized entry point into the fat layer, without a large skin incision.
Its working principle involves three overlapping mechanisms. First, cavitation: the probe vibrating tens of thousands of times per second expands and bursts microscopic bubbles in the anesthetic fluid, and the resulting shock disrupts the membranes of surrounding fat cells. Second, mechanical action from the vibrating probe directly contacting tissue. Third, thermal action from frictional vibration.
Fat cells are relatively vulnerable to this ultrasound vibration, while nerves, blood vessels, and connective tissue are comparatively more resistant. The device is designed to target fat preferentially. However, this does not mean it does not affect anything other than fat. Since heat is also generated, controlling the power and treatment duration is important. The liquefied fat is either absorbed and eliminated naturally or aspirated through a thin cannula.



